SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.
about
High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy.High Expression of 17β-hydroxysteroid Dehydrogenase Type 2 is Associated with a Better Prognosis in Urothelial Carcinoma of the Urinary TractComplement Component 1, s Subcomponent Overexpression is an Independent Poor Prognostic Indicator in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary BladderPrognostic Impact of Thrombospodin-2 (THBS2) Overexpression on Patients with Urothelial Carcinomas of Upper Urinary Tracts and Bladders.Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder.DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study.MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.Stromal SPOCK1 supports invasive pancreatic cancer growth.High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers.CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle.RPN2 promotes colorectal cancer cell proliferation through modulating the glycosylation status of EGFRRegulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma.
P2860
Q33776709-21320DD6-1C7E-4D36-9B60-E9101CBC1EFDQ33820817-66A87917-DCCE-4A9B-8649-8E55A6CB2AE8Q34547656-BCC7E8D9-4EDE-4583-BD01-26DA71002FB0Q37133629-449A07CC-583B-4916-86DB-D63F70D74A1EQ37133687-BAD89C1C-FB76-4A63-9029-355FB110A28AQ37514045-EC5D1A8F-DAA6-4F4D-BEA6-0B285F744722Q37694728-92E9B696-D521-4EBB-A8E1-CAC402C09CDBQ37718437-0FEF6232-6F17-40CA-B00D-F52057CAF8EFQ38685933-2C990613-0D6B-4FBF-AB24-077B52D2BDBDQ41721791-67AEEFAB-B2AE-455E-9A25-8411C142508BQ42292339-DB5A60CB-7EC3-4829-8576-C2059DFB8DF5Q42700759-EEDA9970-DDE5-43B2-9635-12D4B133064EQ50555837-E051B650-9E83-40AA-9825-3417FF2EC43C
P2860
SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.
@ast
SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.
@en
type
label
SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.
@ast
SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.
@en
prefLabel
SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.
@ast
SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.
@en
P2093
P2860
P356
P1433
P1476
SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.
@en
P2093
Chien-Feng Li
Hong-Lin He
I-Wei Chang
Li-Jung Ma
Peir-In Liang
Ting-Feng Wu
Wen-Jen Wu
Yu-Hui Wang
P2860
P304
P356
10.7150/JCA.13625
P577
2016-01-29T00:00:00Z